Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.
Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Joseph Harvey
Dechra Pharmaceuticals has again returned to Australasia for its latest acquisition.
Jaguar Health has opened up a range of commercial possibilities in the Middle East by securing a collaborative partnership with a notable Dubai-based firm.
Canadian business Kane Biotech wants to take its companion animal oral care products to the European sector.
One possible path for Elanco next year could see it become a standalone entity. While this option will have some benefits for Elanco, it would see the firm lose the R&D capabilities its parent company has to offer. Animal Pharm editor Joseph Harvey takes a closer look at the potential situation.
Kindred Biosciences has moved a step closer to US authorization of Zimeta (dipyrone oral gel) for the control of pyrexia in horses.
Boehringer Ingelheim Vetmedica (BIVI) is pre-empting an increased demand for veterinary vaccines by spending $80 million on expanding its existing facilities in Athens, Georgia and St Joseph, Missouri.